Bio-identical Hormone & Peptide Specialists

Table of Contents
Cardio Res-Q Assessment from $775

Advanced labs, the Cleveland Heart panel and Dr. Varano’s evaluation:

Vaping and Heart Risk: What Is Known and What Is Not

Vaping and Heart Risk: What Is Known and What Is Not

Vaping is not harmless for the heart, but its long-term effect on heart attack and stroke is not yet known. E-cigarettes cause measurable short-term changes in heart rate and blood pressure. What is missing is decades of follow-up of the kind that exists for cigarettes.

For someone who smokes, switching completely appears to improve some measures of blood vessel health in the short term. For someone who has never smoked, vaping adds an exposure with no health benefit.

Key takeaways

  • E-cigarettes raise heart rate and blood pressure slightly right after use.
  • No study has yet followed vapers long enough to show what vaping does to heart attack and stroke rates.
  • Using both cigarettes and e-cigarettes is linked with worse outcomes than smoking alone.
  • Expert bodies disagree on vaping as a way to quit smoking, so it is a conversation to have with your clinician.

What vaping does in the short term

An e-cigarette heats a liquid into an aerosol that you inhale. Most liquids contain nicotine, which stimulates the heart and narrows blood vessels.

A pooled analysis of 14 studies with 441 participants measured the immediate effects. Right after e-cigarette use, heart rate rose by about 2 beats per minute, and systolic and diastolic blood pressure each rose by about 2 mmHg. The authors concluded that, unless stronger evidence supports it, the e-cigarette should not be labelled a cardiovascular safe product.1

The American Heart Association reached a similar view in its 2023 scientific statement. It reported that early molecular and clinical evidence suggests various acute physiological effects from e-cigarettes, particularly those containing nicotine.2

What is not known

The honest answer on long-term risk is that nobody knows yet. There are three reasons.

  • Time. Heart disease takes decades to develop, and e-cigarettes have not been in wide use for long enough.
  • Smoking history. Many adults who vape also smoke or used to, which makes it hard to separate the effect of vaping from the effect of cigarettes.
  • Changing products. Devices, liquids and nicotine strengths vary widely and keep changing, so a study of one product may not apply to another.

Regulation adds to the gap. The American Heart Association statement points out that e-cigarettes are regulated as tobacco products, so they do not go through the premarket animal and human safety studies required of a drug or medical device. It describes more clinical research as critically needed.2

What population studies show so far

The largest summary to date pooled 107 population studies published through October 2023. It compared people who vape, people who smoke, people who do both and people who do neither.

ComparisonFinding for cardiovascular disease
Vaping only vs. smoking onlyNo statistically significant difference in odds
Vaping and smoking vs. smoking onlyHigher odds with dual use
Vaping only vs. using neitherHigher odds with vaping

The first row is the one that surprises people. In this analysis, the odds of cardiovascular disease in current e-cigarette users were not statistically different from those in current smokers. The authors concluded that the assumption of substantial harm reduction across all cigarette-caused diseases needs to be reassessed.3

These findings come with a large caveat. Most of the underlying results were cross-sectional, meaning people were asked about vaping and disease at a single point in time. That design cannot show which came first, and many vapers are former smokers whose disease may trace back to cigarettes.

Vaping compared with smoking

One randomized trial looked at what happens inside the blood vessels when smokers switch. It enrolled adults who had smoked at least 15 cigarettes a day for two years or more. Within one month of switching to e-cigarettes, the function of the blood vessel lining and the stiffness of the arteries both improved significantly.4

Two details matter. The people who switched most completely improved the most. And over that month there was no difference in vascular effects between e-cigarettes with nicotine and those without.

The trial lasted one month and measured vessel function, not heart attacks. It supports the idea that a full switch is easier on the blood vessels than continued smoking in the short term. It cannot say whether that advantage lasts.

Why dual use is the worst of both

Many people who take up vaping keep smoking as well. The evidence on this pattern is more consistent than on vaping alone.

In the pooled analysis, people who both smoked and vaped had higher odds of every disease outcome studied than people who only smoked.3 Adding e-cigarettes on top of cigarettes does not reduce harm. If any benefit exists, it appears to depend on stopping cigarettes completely.

Vaping as a way to quit smoking

This is where expert bodies part ways, and it is worth seeing both positions.

A 2025 Cochrane review concluded there is high-certainty evidence that nicotine e-cigarettes increase quit rates compared with nicotine replacement therapy. In absolute terms it estimated about four more people quitting per 100. The reviewers found no evidence of serious harm, but said longer and larger studies are needed to fully evaluate safety.5

The US Preventive Services Task Force took a more cautious line in 2021. It judged the evidence on e-cigarettes for quitting to be insufficient, and recommended that clinicians direct people who use tobacco to cessation methods with proven effectiveness and established safety.6

We do not make a recommendation here. If you smoke and are thinking about how to stop, talk it through with your clinician. Our guide to heart risk after quitting smoking covers how risk changes once you do.

Your next step

Whether you vape, smoke or have done either in the past, tobacco history is one input into your heart risk, and it sits alongside blood pressure, cholesterol and blood sugar. Our guide to a heart disease risk assessment explains how those pieces are put together, and the PREVENT calculator guide shows how smoking status feeds into a risk estimate.

You can also answer the three quick questions in the screener on the Cardio Res-Q program page. Tobacco history is on the list of risk factors the program screens for.

Cardiovascular Risk Screener

Are You a Candidate for Cardio Res-Q?

Three quick questions about the risk factors we screen for. Your answers stay between you and the clinic.

Frequently asked questions

Is vaping better for your heart than smoking?

Possibly in the short term, if you switch completely, but it is not proven for the long term. One trial found better blood vessel function a month after smokers switched. A large pooled analysis of population studies found no clear difference in cardiovascular disease between vapers and smokers. Neither settles the question.

Can vaping cause a heart attack?

It is not known. Vaping raises heart rate and blood pressure slightly right after use, and population studies link it with more cardiovascular disease than using nothing. Long-term studies that could show whether vaping leads to heart attacks have not been done yet.

Is nicotine-free vaping safe for the heart?

There is too little evidence to say. The American Heart Association notes that acute effects are seen particularly with nicotine-containing products. In one month-long trial, though, vessel effects did not differ between e-cigarettes with and without nicotine. Nicotine-free does not mean tested and safe.

I vape and smoke. Is cutting down on cigarettes enough?

The evidence suggests not. People who both smoke and vape had higher odds of disease than people who only smoke in the largest pooled analysis. Talk to your clinician about a plan to stop cigarettes completely.

Related reading

This article is for general education and is not medical advice. Decisions about testing and medication should be made with your clinician. If you have chest pain or other symptoms of a heart attack, call 911.

Optimize Your Health Today!

Cardio Res-Q starts with the $775 Comprehensive or $999 Enhanced Assessment, led by Dr. Varano.

age management doctor philadelphia
Send Us A Message
About Dr. Kenneth Varano, D.O.
age management doctor philadelphia

YoungerMeMD is a physician-led practice in Anti-Aging, Functional and Preventive Medicine, and your care is delivered by our whole clinical team. That team works under Medical Director Kenneth Varano, D.O., who brings over 30 years in clinical medicine and more than 20 years in age management and functional medicine — using science-backed, patient-focused strategies that restore balance, vitality, and health longevity.

About Barbara Dougherty
anti aging treatments

Barbara Dougherty, MSN, CRNP, is a Board-Certified Family Nurse Practitioner and Certified Menopause Practitioner (MSCP) specializing in optimizing hormones, and improving cardio-metabolic health. 

Read Our Reviews

“I’ve been seeing Dr. Varano for just over a year now, and I don’t think I’ve been this healthy and energetic since grade school.

Transform Your Health Today

Ready to take the first step toward renewed energy, balance, and longevity? New patients can register for an initial evaluation to begin their personalized anti-aging journey with YoungerMe MD. Live Younger. Better. Longer. — with YoungerMe MD.

References

  1. Skotsimara G, et al. Cardiovascular effects of electronic cigarettes: A systematic review and meta-analysis. Eur J Prev Cardiol 2019. PMID 30823865 · doi:10.1177/2047487319832975↩
  2. Rose JJ, et al. Cardiopulmonary Impact of Electronic Cigarettes and Vaping Products: A Scientific Statement From the American Heart Association. Circulation 2023. PMID 37458106 · doi:10.1161/CIR.0000000000001160↩
  3. Glantz SA, et al. Population-Based Disease Odds for E-Cigarettes and Dual Use versus Cigarettes. NEJM Evid 2024. PMID 38411454 · doi:10.1056/EVIDoa2300229↩
  4. George J, et al. Cardiovascular Effects of Switching From Tobacco Cigarettes to Electronic Cigarettes. J Am Coll Cardiol 2019. PMID 31740017 · doi:10.1016/j.jacc.2019.09.067↩
  5. Lindson N, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev 2025. PMID 39878158 · doi:10.1002/14651858.CD010216.pub9↩
  6. US Preventive Services Task Force; Krist AH, et al. Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement. JAMA 2021. PMID 33464343 · doi:10.1001/jama.2020.25019↩
Book a Discovery Call Peptide Consult
Close
Book a Discovery Call
Close
Peptide Consult







    Transform Your
    Health & Wellness

    Fill up the form below to get started

      Provocation agent administered prior to timed urine collection (<6hr). Reveals toxic metal burden that can block hormone and peptide response.

      Identifies gluten sensitivity, intestinal permeability (leaky gut), and wheat-related immune reactivity – distinct from standard celiac testing.

      DNA Based stool test detecting pathogens, bacterial imbalances, parasites, and digestive markers – a comprehensive gut microbiome assessment.

      Non-invasive carotid artery ultrasound measuring arterial wall thickness – a direct look at your cardiovascular age.

      Cardio Res-Q cardiac risk panel – inflammation markers and cardiovascular biomarkers beyond standard labs.

      Evaluates intracellular vitamin, mineral, and antioxidant status – foundational to optimizing cellular health and peptide efficacy.

      Full Sex hormone, thyroid and adrenal picture. Identifies imbalances that affect energy, recovery, cognition, and peptide response.

      Advanced testing for immune reactions to wheat, gluten, and intestinal permeability.

      What It Evaluates

      Heavy metals like mercury, lead, cadmium, arsenic, and aluminum can cause:

      Conditions We Identify